GlassScriptPhysician profile
Teresita Devera
NPI 1386985216
$6,654.07
in general payments reported to CMS, 2019-2025
23 companies · $1,019 in 2025
The $1,019 reported for 2025 was more than what 85% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,637 · 2022: $1,640 · 2023: $362 · 2024: $997 · 2025: $1,019.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,377.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $3,791.47 | 2021-2024 | Senza |
| Abbott Laboratories | $1,239.37 | 2021-2025 | Infinity, Eterna, Proclaim |
| Medtronic, INC. | $545.27 | 2021-2025 | Intellis Adaptivestim, Accurian, Vanta Adaptivestim |
| Boston Scientific Corporation | $238.40 | 2021-2025 | General - Dbs, Vercise |
| Si-Bone, INC. | $139.25 | 2022 | |
| Stryker Corporation | $87.87 | 2022 | |
| Ucb, INC. | $75.34 | 2024-2025 | Briviact, Fintepla |
| Argenx US, INC. | $69.90 | 2024-2025 | Vyvgart, Vyvgart Hytrulo |
| Abbvie INC. | $69.06 | 2024-2025 | |
| Stimwave Technologies Incorporated | $56.00 | 2021 | |
| Biogen, INC. | $44.26 | 2024-2025 | Tysabri, Vumerity |
| Neurocrine Biosciences, INC. | $41.76 | 2024-2025 | Ingrezza |
| Biotronik Nro, INC. | $41.37 | 2025 | Prospera |
| Janssen Biotech, INC. | $35.83 | 2025 | |
| Highridge Medical LLC | $26.34 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $24.84 | 2025 | Evoke |
| Merz Pharmaceuticals, LLC | $22.08 | 2025 | Inbrija |
| Alexion Pharmaceuticals, INC. | $19.62 | 2025 | Ultomiris |
| Genentech USA, INC. | $18.68 | 2025 | Ocrevus Zunovo |
| Jazz Pharmaceuticals INC. | $18.63 | 2025 | |
| Brainlab, INC. | $17.50 | 2024 | Surgical Planning and Navigation Radiation Treatment Planning and Positioning |
| Tonix Medicines, INC. | $15.93 | 2025 | Zembrace Symtouch |
| Csl Behring | $15.30 | 2025 | Hizentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Teresita Devera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.